SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009483
Filing Date
2015-11-05
Accepted
2015-11-05 06:31:47
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20150930.htm 10-Q 1279538
2 EX-10.2 nerv-ex102_99.htm EX-10.2 57942
3 EX-31.1 nerv-ex311_8.htm EX-31.1 15200
4 EX-31.2 nerv-ex312_7.htm EX-31.2 14996
5 EX-32.1 nerv-ex321_6.htm EX-32.1 9688
  Complete submission text file 0001564590-15-009483.txt   4818005

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nerv-20150930.xml EX-101.INS 717955
7 XBRL TAXONOMY EXTENSION SCHEMA nerv-20150930.xsd EX-101.SCH 45273
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20150930_cal.xml EX-101.CAL 51386
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20150930_def.xml EX-101.DEF 174319
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20150930_lab.xml EX-101.LAB 359598
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20150930_pre.xml EX-101.PRE 306831
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 151198694
SIC: 2834 Pharmaceutical Preparations